Skip Navigation

Haemophilia Market Access EUMEA Director

Location London, United Kingdom

Haemophilia Market Access EUMEA Associate Director

BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We target illnesses that lack effective therapies and affect relatively small numbers of patients. These conditions are often inherited, difficult to diagnose, progressively debilitating and have few treatment options. BioMarin’s continued focus on advancing therapies that are ‘first and best-in-class’ therapeutics make a meaningful impact. Placing the patient at the heart of everything we do, our mission surrounds a focus on bringing time critical new treatments to the market, significantly faster than the industry average.

As one of the first to go through the new Priority Medicines (PRIME) regulatory initiative in Europe for a New Gene Therapy Treatment for Hemophilia A, we are now looking to build our Market Access team to support the launch of Valrox in 2020 and are looking for the ‘best in class’ talent to shape this journey, in this business-critical role.


Reporting to the EUMEA Market Access Director, this position will be focused on developing and managing the overall market access process for Valrox in the EUMEA region. The role holder will lead projects related to the development of a Pan-European and an in-country access strategy on aligning internal and external stakeholders to navigate the potential access hurdles. The role will act as a support for the local implementation of the strategy, through active collaboration with country and regional teams. As such, this role requires someone with an understanding of rare-disease and haemophilia policies and processes that are relevant to and could impact access conditions.


  • Maintain and manage the patient access strategy for Valrox across the EUMEA region.
  • Coordinate the market access taskforce responsible for;
    • ensuring alignment of the external stakeholders (payers, physicians, patient groups, politicians) to ensure a supportive market access environment for Valrox;
    • all relevant internal stakeholders are aligned on the strategy and tactics required for obtaining timely access to Valrox in the various countries
  • In collaboration with the Area Directors and Zone leads, the development of strategies for the negotiations and contracting discussions with various payer institutions (with support from the global pricing team)
  • In collaboration with the reimbursement manager and the country teams, support the development of reimbursement submissions and responses to objections from payer bodies by obtaining external stakeholder input where relevant
  • Support maintenance of current information on policy changes in the region which could impact our haemophilia
  • Planning, organising and managing resources to bring about the successful completion of specific project goals and objectives
  • Liaise with local Area Directors and country managers to support timely delivery of strategic goals and projects e.g. ad boards, market access materials, evidence projects (aligned with health economics and medical)
  • Maintain compliance in accordance with the BioMarin procedures and the relevant local and European requirements


  • The ideal candidate will have substantial Market Access experience (ideally 10+ years) obtained from either a consulting or industry background (governmental affairs, patient advocacy or policy backgrounds may also be considered)
  • Prior experience in Hemophilia and/or gene therapy, innovative medicines, or rare diseases would be preferable
  • A sound knowledge and experience of the payer environment, ideally across multiple EU countries with a good knowledge of local consultancies is required
  • Demonstrated ability to navigate through political pressures, building a strong stakeholder community through reimbursement, with strong strategic planning and organizational aptitude
  • The post holder should be self-reliant, results orientated with a sense of urgency to get things done, confident in working independently to find solutions
  • Working knowledge of the ABPI code is preferable
  • Willingness to travel within EUMEA region will be necessary

About our location



Hiring Insights

We treat rare diseases, and that gives us rare opportunities. Chris Brodeur, Director, Corporate Compliance
Return to the top of the page